![](/img/cover-not-exists.png)
217TiP Dose-finding phase Ib study of FOLFOXIRI plus ramucirumab as first-line therapy for patients with metastatic colorectal cancer
Yamazaki, K., Kito, Y., Esaki, T., Satake, H., Taniguchi, H., Tsuda, T., Denda, T., Moriwaki, T., Mori, K.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw581.049
Date:
December, 2016
File:
PDF, 50 KB
english, 2016